Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.
about
Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axesPenetration of fosfomycin into IPEC-J2 cells in the presence or absence of deoxynivalenolGene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting.Synthesis and characterization of a new and radiolabeled high-affinity substrate for H+/peptide cotransporters.Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.The oligopeptide transporter hPepT1: gateway to the innate immune response.Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety.Transporter-mediated uptake into cellular compartments.Pharmaceutical and pharmacological importance of peptide transporters.Modeling kinetics of subcellular disposition of chemicals.Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestineMitigating permeability-mediated risks in drug discovery.Targeting receptors, transporters and site of absorption to improve oral drug delivery.Everted gut sac model as a tool in pharmaceutical research: limitations and applications.Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.l-Tryptophan Activates Mammalian Target of Rapamycin and Enhances Expression of Tight Junction Proteins in Intestinal Porcine Epithelial Cells.Clinical relevance of intestinal peptide uptake.Cinnamicaldehyde regulates the expression of tight junction proteins and amino acid transporters in intestinal porcine epithelial cells.The steady-state serum concentration of genistein aglycone is affected by formulation: a bioequivalence study of bone productsPotential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically.Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells.Intestinal absorption of amino acids in the Pacific bluefin tuna (Thunnus orientalis): in vitro lysine-arginine interaction using the everted intestine system.Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers.Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats
P2860
Q24810345-95B73E0C-39D9-4942-9B86-FF4B7956D3EBQ28536930-2DE81D3B-0B9E-4E82-9B57-92C99CD8E90CQ33293463-E6E50464-C02E-48BE-A64D-0EACB5B63E71Q33303049-AA4ECE34-0A4E-4C06-8621-245AEA456135Q33697974-3F39698C-A0E8-4735-8357-095694DF6C89Q34749181-3B97A2F9-4270-4299-89BC-C33C4266202AQ36088451-78287A5A-C7FE-47DB-A320-5B8A9DE38A4FQ36406899-10D27984-9AD7-4A2A-B18B-6C01B424995EQ36465426-66A8EA17-368C-43C0-AED2-FF5A80C76C49Q36744766-8BECFE89-B72E-420A-9988-D914D04AD232Q36960535-93F752A0-E0F4-4B96-97FD-9C1191AEA899Q36985076-C89DBB31-72DE-4ABE-86FB-FDF33F94434BQ37139860-0166E61C-8068-412B-A9E4-DD8A6791112AQ37194304-D7DC0AF8-6F5B-4A5A-9CE1-55D46CB91B0FQ37214548-5F0D9AD7-F145-46BB-B65A-D4003EE4FB42Q37671826-4020C0C9-5B8B-4B73-8277-CF61CADD2F34Q37928909-3BB74634-6CB1-402A-8101-F8FE5E2D7D3DQ37981723-CA63AD1E-8A20-45DA-8856-D37CBEDD5025Q38202698-06CCE276-4D44-4F3B-94FA-0DAEA6A0DBEFQ38886658-F7A1D78C-BAFF-44EE-9738-175D9BCC77CEQ40244905-554EDA71-D9D2-4550-9459-E801801FAE59Q41438858-BB1A3E8A-43C4-4356-9277-C1542B6EA741Q41484340-45E3FD69-9773-494E-BB8D-1D4EA2DA2DC5Q41891370-2440F663-58CD-4498-B6EC-897CC355B0D1Q43269139-75BC2185-88BD-49B9-93C6-16505BEAF84BQ45349220-CE1429D7-C37B-4216-9883-E9A15591E073Q46725879-A26DCA8F-2B11-486D-BD1E-8758EAEFE179Q53395753-37F3DAD3-A65E-4D80-A326-D8239F98EAA2Q57119123-D793A370-641F-4986-AA39-123DC1288C68
P2860
Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intestinal solute carriers: an ...... mproving oral drug absorption.
@ast
Intestinal solute carriers: an ...... mproving oral drug absorption.
@en
type
label
Intestinal solute carriers: an ...... mproving oral drug absorption.
@ast
Intestinal solute carriers: an ...... mproving oral drug absorption.
@en
prefLabel
Intestinal solute carriers: an ...... mproving oral drug absorption.
@ast
Intestinal solute carriers: an ...... mproving oral drug absorption.
@en
P2093
P1476
Intestinal solute carriers: an ...... mproving oral drug absorption.
@en
P2093
André Huss Eriksson
Bente Steffansen
Carsten Uhd Nielsen
Rikke Andersen
Sven Frokjaer
P356
10.1016/J.EJPS.2003.10.010
P407
P577
2004-01-01T00:00:00Z